Results 31 to 40 of about 1,182,968 (316)
BMC Musculoskeletal Disorders, 2019 Background Lithium, an established psychiatric medication, has recently been shown to enhance new bone formation in preclinical fracture models. Current research is focused on evaluating the efficacy of low-dose, short-term lithium treatment to improve ...
Kathak Vachhani +3 more
doaj +1 more source
A mixed methods analysis of lithium-related patient safety incidents in primary care
Therapeutic Advances in Drug Safety, 2020 Background: Lithium is a drug with a narrow therapeutic range and has been associated with a number of serious adverse effects. This study aimed to characterise primary care lithium-related patient safety incidents submitted to the National Reporting and
Richard Simon Young +5 more
doaj +1 more source
Effect of antipsychotics on serum lithium levels and white blood cell counts
Neuropsychopharmacology Reports, 2021 Lithium carbonate is used to increase white blood cell counts as a means of counteracting leukopenia caused by the administration of antipsychotic drugs.
Ryo Obara +5 more
doaj +1 more source
Biological effects of lithium – fundamental and medical aspects [PDF]
The Ukrainian Biochemical Journal, 2017 In this review, the authors present data on the biological effects of lithium in human and animal body and the subsequent manifestations of these effects. Since the lithium ion radius is close to that of magnesium, lithium ion can compete with magnesium as cofactor of certain magnesium-dependent enzymes.
A. S. Mikosha +2 more
openaire +3 more sources
Frontiers in Psychiatry, 2021 Objective: This study aimed to examine the treatment-related changes of the fractional amplitude of low-frequency fluctuations (fALFF) in the default mode network (DMN) across different bands after the medication-free patients with bipolar II depression ...
Jun Zhou +10 more
semanticscholar +1 more source
Saudi Journal of Medicine and Medical Sciences, 2023 Background: Medication errors can result in adverse drug events (ADEs) and cause considerable patient harm. Limited data are available from Saudi Arabia and the Middle East regarding the prevalence of preventable adverse drug events (pADEs) in primary ...
Ghadah A Assiri +4 more
doaj +1 more source
European Archives of Psychiatry and Clinical Neuroscience, 2021 The effect of concomitant medication on repetitive transcranial magnetic stimulation (rTMS) outcomes in depression remains understudied. Recent analyses show attenuation of rTMS effects by antipsychotic medication and benzodiazepines, but data on the ...
T. Hebel +8 more
semanticscholar +1 more source
Population Pharmacokinetics and Dosing Regimen of Lithium in Chinese Patients With Bipolar Disorder
Frontiers in Pharmacology, 2022 Background: Lithium is an effective medication approved for the treatment of bipolar disorder (BD). It has a narrow therapeutic index (TI) and requires therapeutic drug monitoring.
Zi-bin Jin +7 more
doaj +1 more source
Lithium-related medication problems on nonpsychiatric inpatient medical units
American Journal of Health-System Pharmacy, 2019 Abstract Purpose Results of a study of medication-related problems (MRPs) associated with lithium use on nonpsychiatric inpatient medical units are reported. Methods In a single-center, retrospective study, the records of all patients
Ericka L. Crouse +2 more
openaire +3 more sources
Facial processing in bipolar disorder is mediated by clinical and biological aspects
Brazilian Journal of Psychiatry, 2022 Objective: The process of detecting faces can be considered one of the initial steps in face recognition, which is essential for human interaction. We sought to investigate whether a face perception task reliably detects subtle perceptual disturbances ...
Irina I. Shoshina +6 more
doaj +1 more source